FSSAI approved the revised list of Inborn Errors of Metabolism
The new list shall come into effect from the beginning of next financial year i.e 1st April, 2022.
RBI publishes Reserve Bank of India (Credit Derivatives) Directions, 2022.
Residents and non-residents who are eligible to invest in corporate bonds and debentures under the Foreign Exchange Management (Debt Instruments) Regulations 2019 will be eligible to participate in the credit derivatives market.
The Medical Devices ( Draft Amendment) Rules, 2022.
The Registration Certificate issued in Form MD-42, shall remain valid in perpetuity, subject to payment of Registration Certificate retention fee as specified in the Second Schedule before completion of the period of five years from the date of its issue, unless, it is suspended or cancelled by State Licensing Authority.
MoHFW issues revised guidelines for international arrivals.
The ministry has removed the list of at-risk countries and on arrival only thermal screening would be carried out in respect of all the passengers by the health officials present at the airport.
RBI reviews Rupee Interest Rate Derivatives Directions.
Non-residents may also undertake FCS-OIS transactions with the market-makers having AD Cat-I license for purposes other than hedging interest rate risk. These transactions may be undertaken directly with a market-maker in India, or by way of a ‘back-to-back’ arrangement through a foreign branch of the market-maker or through their IBUs.
Registrars of universities directed to provide information regarding accessibility of online education to Persons with Disabilities
With a view to develop guidelines for ensuring accessibility of online education to Persons with Disabilities especially during Covid times, You are requested to kindly furnish the point wise reply to each of the points in the checklist available at link https://uamp.usc.ac.in/ latest by 15.02.2022.
Relaxation in Drugs Rules and New Drugs and Clinical Trials Rules for making available suitable drugs to meet the requirements arising due to COVID-19
The Central License Approving Authority or the State Licensing Authority, as the case may be, if satisfied that requirements under the provisions of the said Act and the Drugs Rules, 1945 and the New Drugs and Clinical Trials Rules, 2019 have been complied with, grant License to manufacture and stock the new drug subject to the condition that the licensee shall sell or distribute the new drug only after obtaining permission for such new drug in Form CT-23.
Documents to be submitted to avail benefits of Netaji Subhas ICAR International Fellowship
It is clarified that till the time Aadhaar is assigned to the beneficiary, benefits under the Scheme shall be given to such beneficiaries subject to production prescribed documents.
The Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) (Amendment) Regulations, 2022.
A resolution professional may convene a meeting of the committee as and when he considers necessary and if he considers it necessary, on a request received from members of the committee and shall convene a meeting if the same is made by members of the committee representing at least thirty three per cent of the voting rights.
ESIC relaxes the eligibility condition under ESIC COVID-19 Relief Scheme.
The deceased Insured Person must have been in employment on the date of diagnosis of COVID19 disease and contributions for at least 35 days should have been paid or payable in respect of him / her during a period of maximum one year immediately preceding the diagnosis of COVID-19 disease resulting in death.
